Clinical improvement in psoriasis with specific targeting of interleukin-23 - Kopp, Tamara; Riedl, Elisabeth; Bangert, Christine; Bowman, Edward P.; Greisenegger, Elli; Horowitz, Ann; Kittler, Harald; Blumenschein, Wendy M.; McClanahan, Terrill K.; Marbury, Thomas; Zachariae, Claus; Xu, Danlin; et al. (Nature (London), 2015)
Keywords: 13; 38/1; 692/699/249/1313/1758; Adolescent; Adult; Aged; Antibodies, Monoclonal - adverse effects; Antibodies, Monoclonal - immunology; Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal - therapeutic use; Binding sites; Care and treatment; Cytokines; Double-Blind Method; Epithelium - drug effects; Epithelium - pathology; Gene expression; Gene Expression Regulation - drug effects; Health aspects; Humanities and Social Sciences; Humans; Immunotherapy; Interleukin-23 - antagonists & inhibitors; Interleukin-23 - chemistry; Interleukin-23 - immunology; Interleukins; letter; Ligands; Middle Aged; Molecular Targeted Therapy; multidisciplinary; Patient outcomes; Protein Subunits - antagonists & inhibitors; Protein Subunits - chemistry; Protein Subunits - immunology; Psoriasis; Psoriasis - drug therapy; Psoriasis - immunology; Psoriasis - metabolism; Psoriasis - pathology; Science; Skin - drug effects; Skin - immunology; Skin - metabolism; Skin - pathology; Skin diseases; Studies; Treatment Outcome; Young Adult